News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,007 Results
Type
Article (5005)
Company Profile (17)
Press Release (218985)
Section
Business (82215)
Career Advice (461)
Deals (15042)
Drug Delivery (8)
Drug Development (19059)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120116)
Policy (7499)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (291)
Adcomms (3)
Allergies (8)
Alliances (14755)
ALS (15)
Alzheimer's disease (236)
Antibody-drug conjugate (ADC) (8)
Approvals (3685)
Artificial intelligence (34)
Autoimmune disease (2)
Automation (2)
Bankruptcy (96)
Best Places to Work (2863)
Biosimilars (10)
Biotechnology (21)
Bladder cancer (7)
Brain cancer (7)
Breast cancer (42)
Cancer (385)
Cardiovascular disease (19)
Career advice (391)
Career pathing (2)
CAR-T (27)
Cell therapy (95)
Cervical cancer (2)
Clinical research (15931)
Collaboration (144)
Compensation (132)
Complete response letters (2)
COVID-19 (300)
CRISPR (7)
C-suite (81)
Cystic fibrosis (15)
Data (434)
Depression (5)
Diabetes (35)
Diagnostics (2029)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (40442)
Editorial (1)
Employer branding (6)
Employer resources (31)
Events (37534)
Executive appointments (262)
FDA (3880)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (157)
Gene editing (14)
Generative AI (2)
Gene therapy (39)
GLP-1 (102)
Government (406)
Guidances (15)
Healthcare (5032)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (11)
Indications (5)
Infectious disease (314)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (13)
Interviews (53)
IPO (7810)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (4)
Legal (2330)
Liver cancer (17)
Lung cancer (42)
Lymphoma (23)
Management (10)
Manufacturing (44)
MASH (24)
Medical device (3855)
Medtech (3856)
Mergers & acquisitions (7402)
Metabolic disorders (105)
Multiple sclerosis (5)
NASH (6)
Neurodegenerative disease (7)
Neuropsychiatric disorders (1)
Neuroscience (311)
NextGen: Class of 2025 (1673)
Non-profit (729)
Northern California (798)
Now hiring (2)
Obesity (48)
Opinion (30)
Ovarian cancer (14)
Pain (10)
Pancreatic cancer (12)
Parkinson's disease (19)
Partnered (4)
Patents (20)
Patient recruitment (23)
Peanut (4)
People (24462)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4753)
Phase II (6921)
Phase III (5504)
Pipeline (396)
Policy (4)
Postmarket research (625)
Preclinical (1848)
Press Release (66)
Prostate cancer (25)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (60)
Real estate (1873)
Recruiting (8)
Regulatory (5070)
Reports (13)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (2)
Schizophrenia (17)
Series A (24)
Series B (17)
Sickle cell disease (7)
Southern California (592)
Special edition (1)
Sponsored (3)
Startups (1009)
Stomach cancer (1)
Supply chain (9)
United States (6121)
Vaccines (33)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (9)
Last 7 days (206)
Last 30 days (842)
Last 365 days (10459)
2025 (1778)
2024 (11030)
2023 (13195)
2022 (18664)
2021 (19680)
2020 (18242)
2019 (13209)
2018 (10211)
2017 (10004)
2016 (9159)
2015 (12121)
2014 (9591)
2013 (7708)
2012 (8329)
2011 (8798)
2010 (8636)
Location
Africa (183)
Alabama (13)
Alaska (2)
Arizona (54)
Arkansas (1)
Asia (11396)
Australia (1592)
California (1653)
Canada (622)
China (53)
Colorado (70)
Connecticut (84)
Delaware (24)
Europe (24323)
Florida (223)
Georgia (28)
Idaho (23)
Illinois (104)
India (4)
Indiana (55)
Japan (59)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (38)
Maryland (201)
Massachusetts (1352)
Michigan (81)
Minnesota (127)
Mississippi (1)
Missouri (20)
Montana (16)
Nebraska (12)
Nevada (21)
New Hampshire (15)
New Jersey (491)
New Mexico (5)
New York (416)
North Carolina (298)
North Dakota (2)
Northern California (798)
Ohio (49)
Oklahoma (4)
Oregon (3)
Pennsylvania (300)
Rhode Island (11)
South America (274)
South Carolina (4)
Southern California (592)
Tennessee (32)
Texas (195)
Utah (54)
Virginia (33)
Washington D.C. (7)
Washington State (145)
West Virginia (2)
Wisconsin (17)
224,007 Results for "insulet corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
Insulet Corporation released its 2023 Sustainability Report, which describes key accomplishments in environmental, social, and governance areas in 2023.
May 7, 2024
·
4 min read
Genetown
Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today shared positive results from its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) type 2 diabetes pivotal trial at the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, Florida.
June 21, 2024
·
8 min read
Genetown
Insulet to Present at the 2024 Jefferies Global Healthcare Conference
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m.
May 28, 2024
·
1 min read
Press Releases
Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year
February 21, 2025
·
19 min read
Press Releases
Insulet to Present at Upcoming Investor Conferences
November 15, 2024
·
1 min read
Press Releases
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
January 10, 2025
·
1 min read
Business
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months ended March 31, 2024.
May 9, 2024
·
15 min read
Genetown
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, made several exciting announcements regarding the Omnipod 5 Automated Insulin Delivery System, including its availability in France with Dexcom G6 compatibility, as well as two updates for the U.S. market — the commencement of the Omnipod 5 with Dexcom G7 integration full commercial launch as well as the limited market release of the Omnipod 5 App for iPhone.
June 20, 2024
·
5 min read
Genetown
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that Omnipod 5, compatible with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitor sensors, is now fully available in the U.K. and the Netherlands for individuals aged two years and older with type 1 diabetes.
June 20, 2024
·
4 min read
Business
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced plans to release its financial results for the first quarter of 2024 on May 9, 2024 after the close of the financial markets.
April 3, 2024
·
1 min read
1 of 22,401
Next
